Author:
Alrusayyis Nawaf Saad,Alghamdi Khaled Mohammed,Alahmari Bassam Mana,Barnawi Ruba Mahmoud,Alfuraydan Ali Yousef A,Alharbi Bader Aziz,Alwaladali Mohammed Salamah
Reference30 articles.
1. Alshammari, Y. H. M., Aldoghmi, A. K. B., Al Afif, H. S. A., Alfayi, B. A., Alrebh, A. H., Alsayafi, Z. A., Fatani, Y. A., Aldughmi, A. N., Alzaidan, A. M., Alsubaiei, S. A. O., et al. (2019). Multiple Sclerosis Diagnosis and Management: A simple Literature Review. Archives of Pharmacy Practice, 10(4), 33-37.
2. Berkovich, R. (2013). Treatment of acute relapses in multiple sclerosis. Neurotherapeutics, 10(1), 97-105.
3. Burton, J. M., O'Connor, P. W., Hohol, M., Beyene, J., & Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group. (1996). Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. Cochrane Database of Systematic Reviews, 2012(12), Cd006921.
4. Correia, I., Ribeiro, J. J., Isidoro, L., Batista, S., Nunes, C., Macário, C., Borges, C., Tomaz, J., & Sousa, L. (2018). Plasma exchange in severe acute relapses of multiple sclerosis–Results from a Portuguese cohort. Multiple Sclerosis and Related Disorders, 19, 148-152.
5. Cortese, I., Chaudhry, V., So, Y. T., Cantor, F., Cornblath, D. R., & Rae-Grant, A. (2011). Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology, 76(3), 294-300.